Tech Company Financing Transactions
MaximBio Funding Round
MaximBio, based in Rockville, scored $49.5 million from United States Department of Health and Human Services (HHS).
Transaction Overview
Company Name
Announced On
1/4/2024
Transaction Type
Venture Equity
Amount
$49,500,000
Round
Undisclosed
Proceeds Purpose
This funding is designated to fortify the domestic manufacturing capabilities for diagnostic tests and enhance preparedness for potential future pandemics.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1500 East Gude Drive A
Rockville, MD 20850
USA
Rockville, MD 20850
USA
Phone
Website
Email Address
Overview
Maxim Biomedical (MaximBio) is a leading diagnostic healthcare company enhancing global health through the development and manufacture of trusted diagnostic solutions. Our mission is to create diagnostic products that are affordable, accessible, and enable actionable testing to improve patient outcomes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joe Maa
Chief Financial Officer
George Scheeler
Chief Operating Officer
Jonathan Maa
Vice President
Sophie Su
Browse more venture capital transactions:
Prev: 1/4/2024: Avistone Biotechnology venture capital transaction
Next: 1/4/2024: UniFAHS venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here come from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs